DLL3 and Merkel cell skin cancer: SCNEC (90/112, 80.4%) and Merkel cell carcinoma (13/15, 86.7%) showed a significantly higher frequency of DLL3 expression (any degree; p < 0.001) compared to LCNEC (82/131, 62.6%) and MiNEN (16/56, 28.6%).